Home
Conditions
Adenocarcinoma, Follicular

Clinical trial condition

Adenocarcinoma, Follicular

Explore clinical trials studying Adenocarcinoma, Follicular. Study availability and eligibility vary by location and protocol.

53 public trials 6 recruiting studies

Refine in advanced search Browse all conditions

Adenocarcinoma, Follicular trial results

Completed

Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu

NCT00004074

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +257 more
Locations: Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

NCT00005842

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +135 more
Locations: Brooke Army Medical Center Fort Sam Houston, Texas, United States

Institute for Drug Development San Antonio, Texas, United States

View Trial Details

Completed

Gefitinib in Treating Patients With Metastatic or Unresectable Head and Neck Cancer or Non-Small Cell Lung Cancer

NCT00068497

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +132 more
Locations: Southwest Oncology Group San Antonio, Texas, United States

View Trial Details

Completed

NGR-TNF in Treating Patients With Advanced Solid Tumors

NCT00098943

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +60 more
Locations: University Medical Center Hamburg - Eppendorf Hamburg, Germany

Universitair Medisch Centrum St. Radboud - Nijmegen Nijmegen, Netherlands

View Trial Details

Completed

Boronophenylalanine-Fructose Complex (BPA-F) and/or Sodium Borocaptate (BSH) Followed By Surgery in Treating Patients With Thyroid Cancer, Head and Neck Cancer, or Liver Metastases

NCT00062348

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +46 more
Locations: Universitaetsklinikum Essen Essen, Germany

View Trial Details

Completed

SU5416 and Paclitaxel in Treating Patients With Recurrent, Locally Advanced or Metastatic Cancer of the Head and Neck

NCT00005647

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Carcinoma, +38 more
Locations: Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Active, Not Recruiting

Testing the Combination of Cabozantinib, Nivolumab, and Ipilimumab (CaboNivoIpi) for Advanced Differentiated Thyroid Cancer

NCT03914300

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +20 more
Locations: City of Hope Comprehensive Cancer Center Duarte, California, United States

Los Angeles General Medical Center Los Angeles, California, United States

USC / Norris Comprehensive Cancer Center Los Angeles, California, United States

USC Norris Oncology/Hematology-Newport Beach Newport Beach, California, United States

View all 33 locations

View Trial Details

Active, Not Recruiting

IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients

NCT01398085

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +13 more
Locations: Belfast Health and Social Care Trust Belfast, United Kingdom

University Hospitals Birmingham NHS Foundation Trust Birmingham, United Kingdom

University Hospitals Sussex NHS Foundation Trust Brighton, United Kingdom

University Hospital Bristol NHS Foundation Trust Bristol, United Kingdom

View all 36 locations

View Trial Details

Active, Not Recruiting

Trametinib in Increasing Tumoral Iodine Incorporation in Patients With Recurrent or Metastatic Thyroid Cancer

NCT02152995

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +23 more
Locations: Memorial Sloan Kettering Cancer Center New York, United States

View Trial Details

Active, Not Recruiting

Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer

NCT04948437

Conditions: Adenocarcinoma, Adenocarcinoma, Follicular, Adenocarcinoma, Papillary, +14 more
Locations: Chih-Yuan Wang, M.D Taipei, Taiwan

View Trial Details

Adenocarcinoma, Follicular

Adenocarcinoma, Follicular trial results

Related conditions